: Out of 18 analysts, 22% recommend a "Strong Buy," 39% a "Buy," and 39% a "Hold." No analysts currently suggest "Sell".
: 12-month projections range from $114 to $150, with recent targets from Wells Fargo at $150 and UBS at $145. 3. Bull Case (Reasons to Buy)
The investment case for as of April 2026 presents a "Buy" consensus from Wall Street, balanced by near-term volatility and a critical upcoming patent cliff. 1. Market Snapshot Current Price : $110.23 (as of April 27, 2026). Market Capitalization : $272.25 billion. Valuation : Trading at a P/E ratio of approximately 15.14x. Dividend Yield : 3.08%. Merck & Co Inc (MRK) -1.46% today Closed: 3:00 PM • Disclaimer After hours: 5:20 PM Apr 27, 2026 8:30 AM - 5:20 PM Open111.22 Mkt cap$272.25B USD 52-wk high125.14 High112.75 P/E ratio15.14 52-wk low73.31 Div yield3.08% 2. Investment Rating: Buy or Sell? Analyst Consensus : Strong "Buy" leaning.
